{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:37:23Z","timestamp":1781894243488,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:00:00Z","timestamp":1712448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Residual neuromuscular blockade has been linked to pulmonary complications in the postoperative period. This study aimed to determine whether sugammadex was associated with a lower risk of postoperative pulmonary complications (PPCs) compared with neostigmine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study was conducted in a tertiary academic medical center. Patients \u226518\u2009year of age undergoing noncardiac surgical procedures with general anesthesia and mechanical ventilation were enrolled between January 2019 and September 2021. We identified all patients receiving rocuronium and reversal with neostigmine or sugammadex via electronic medical record review. The primary endpoint was a composite of PPCs (including pneumonia, atelectasis, respiratory failure, pulmonary embolism, pleural effusion, or pneumothorax). The incidence of PPCs was compared using propensity score analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1786 patients were included in this study. Among these patients, 976 (54.6%) received neostigmine, and 810 (45.4%) received sugammadex. In the whole sample, PPCs occurred in 81 (4.54%) subjects (7.04% sugammadex <jats:italic>vs<\/jats:italic>. 2.46% neostigmine). Baseline covariates were well balanced between groups after overlap weighting. Patients in the sugammadex group had similar risk (overlap weighting OR: 0.75; 95% CI: 0.40 to 1.41) compared to neostigmine. The sensitivity analysis showed consistent results. In subgroup analysis, the interaction <jats:italic>P<\/jats:italic>\u2010value for the reversal agents stratified by surgery duration was 0.011.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There was no significant difference in the rate of PPCs when the neuromuscular blockade was reversed with sugammadex compared to neostigmine. Patients undergoing prolonged surgery may benefit from sugammadex, which needs to be further investigated.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.16056","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T23:14:50Z","timestamp":1712531690000},"page":"1667-1676","source":"Crossref","is-referenced-by-count":3,"title":["Association between reversal agents (sugammadex <i>vs<\/i>. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis"],"prefix":"10.1111","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0067-799X","authenticated-orcid":false,"given":"Aolin","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihan","family":"Fan","sequence":"additional","affiliation":[{"name":"Nanjing Medical University  Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhang","family":"Xu","sequence":"additional","affiliation":[{"name":"Hubei University of Medicine  Shiyan Hubei Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dutian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxuan","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Jiangnan University Medical Center (Wuxi No.2 People's Hospital of Nanjing Medical University)  Wuxi Jiangsu Province China"},{"name":"Nanjing Medical University  Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,7]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.2471\/blt.15.159293"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjaed\/mkx012"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/265165"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aex002"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31821f0522"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213\u20102600(18)30294\u20107"},{"issue":"7","key":"e_1_2_11_8_1","first-page":"735","article-title":"Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex","volume":"82","author":"Martinez\u2010Ubieto J","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181cded07"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.03.029"},{"issue":"2","key":"e_1_2_11_11_1","first-page":"49","article-title":"A review of the interest of sugammadex for deep neuromuscular blockade management in Belgium","volume":"64","author":"Dubois PE","year":"2013","journal-title":"Acta Anaesthesiol Belg"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0000000000005842"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd012763"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0000000000003735"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/eja.0000000000000010"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0000000000003256"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(07)61602\u2010x"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041232"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.02.007"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy201"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq439"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/wics.1460"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt312"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14749"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.02.021"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15940"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2022.04.023"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.04.026"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00540\u2010021\u201002910\u20102"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.01.016"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12630\u2010019\u201001419\u20103"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12871\u2010023\u201002094\u20100"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181fc6e0a"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0000000000002670"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.16056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T08:50:41Z","timestamp":1719478241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.16056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1111\/bcp.16056"],"URL":"https:\/\/doi.org\/10.1111\/bcp.16056","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,7]]}}}